ARTICLE | Clinical News
Geron preclinical data
January 11, 2010 8:00 AM UTC
In mouse xenograft models of glioblastoma, imetelstat significantly reduced tumor growth rate and led to a 10-fold decrease in tumor size after 53 days of treatment vs. vehicle. Imetelstat also inhibi...